
Christopher Allen Berger MD
Critical Care Medicine, Pleural Disease
Resident Physician, Internal Medicine, UCSF School of Medicine
Join to View Full Profile
9500 Euclid AveMail Code M8 AnnexCleveland, OH 44195
Phone+1 415-476-1528
Fax+1 415-502-1976
Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2012 - 2015
- University of Pittsburgh School of MedicineClass of 2012
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine
Certifications & Licensure
- CA State Medical License 2014 - 2026
- OH State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Predicted choice and acceptability of regimens for tuberculosis preventive treatment among people living with HIV in Uganda - a discrete choice experiment.Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto
Medrxiv. 2025-03-13 - 1 citationsPreferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto
Journal of the International AIDS Society. 2024-12-01 - Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, Lydia Akello, Fred Welishe
Open Forum Infectious Diseases. 2024-11-01
Grant Support
- Digital adherence technologies to facilitate completion of short-course tuberculosis preventive therapy among people living with HIVUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: